Stocks in play: MediPharm Labs Corp.
Provided an update on significant progress made on the integration of VIVO Cannabis Inc.'s operations following the completion of its plan of arrangement with VIVO, pursuant to which MediPharm acquired all of the issued and outstanding common shares of VIVO in an all-equity business combination transaction effective April 1. MediPharm Labs Corp. shares T.LABS are trading up $0.01 at $0.08.
Provided Content: Content provided by Baystreet. The Globe and Mail was not involved, and material was not reviewed prior to publication.
